Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as Ozempic that have been plagued with supply issues.
That’s the prediction from Australian diabetes experts, as the first phase three clinical trial data was released for a new type of medicine that lowers blood sugar.
